UB CIGBS International Scholar attends ACTG Annual Meeting

This past June, Dr. Waheed Adedeji, an International Scholar, traveled to Washington D.C. to attend the AIDS Clinical Trials Group (ACTG) Annual Meeting. Dr. Adedeji is from the University of Ibadan in Nigeria and the recipient of the prestegious HIV Research Trust Award. As an international researcher and physician, Adedeji used this opportunity to network with other researchers and attend presentations about the advancements in research, drug development, and clinical practices pertaining to HIV/AIDS.

The ACTG Annual Meeting is a major international conference representing work and developments from 34 US and 30 foreign clinical research sites. The ACTG Network is the largest HIV/AIDS clinical group in the world, and their mission is “to cure HIV infection and reduce the burden of disease due to HIV infection and its complications, including tuberculosis and viral hepatitis”.

The University at Buffalo is one of the 34 US ACTG clinical research sites, and was represented at the Annual Meeting. From CIGBS the representees were:

• Gene Morse, PharmD - ACTG PSL Director
  
• Robin DiFrancesco, MBA - Clinical Pharmacology Quality Assurance Program Manager
  
• Qing Ma, PhD
  
• Charles Maponga, PharmD - University of Zimbabwe PSL lab Director
  
• Charles Venuto, PharmD
  

Adedeji is the first Center for Integrated Global Biomedical Sciences (CIGBS) scholar. He is currently training and researching under the mentorship of Gene Morse, PharmD, Fatai Fehintola, MBBS, MsC, FMCP and Qing Ma, PhD. Waheed’s research is focused on the Pharmacokinetics and Pharmacodynamics of certain antidepressants and their interaction with antiretroviral drugs used to treat HIV/AIDS in Nigeria.

To learn more about the ACTG Network, click here. To learn more about UB CIGBS, click here.